Your browser doesn't support javascript.
loading
Verification of the minimal clinically important difference of the Capabilities of Upper Extremity Test in patients with subacute spinal cord injury.
Jimbo, Kazumasa; Miyata, Kazuhiro; Yuine, Hiroshi; Takahama, Kousuke; Yoshimura, Tomohiro; Shiba, Honoka; Yasumori, Taichi; Kikuchi, Naohisa; Shiraishi, Hideki.
Afiliação
  • Jimbo K; Graduate School of Health Sciences, Ibaraki Prefectural University of Health Sciences, Ami, Japan.
  • Miyata K; Department of Rehabilitation Treatment, Chiba Rehabilitation Center, Chiba, Japan.
  • Yuine H; Department of Physical Therapy, Ibaraki Prefectural University of Health Sciences, Ami, Japan.
  • Takahama K; Department of Occupational Therapy, Ibaraki Prefectural University of Health Sciences, Ami, Japan.
  • Yoshimura T; Department of Rehabilitation Treatment, Chiba Rehabilitation Center, Chiba, Japan.
  • Shiba H; Department of Rehabilitation Treatment, Chiba Rehabilitation Center, Chiba, Japan.
  • Yasumori T; Department of Rehabilitation Treatment, Chiba Rehabilitation Center, Chiba, Japan.
  • Kikuchi N; Department of Rehabilitation Treatment, Chiba Rehabilitation Center, Chiba, Japan.
  • Shiraishi H; Department of Rehabilitation Medicine, Chiba Rehabilitation Center, Chiba, Japan.
J Spinal Cord Med ; : 1-8, 2023 Nov 06.
Article em En | MEDLINE | ID: mdl-37930635
ABSTRACT
CONTEXT The number of patients with cervical spinal cord injury (CSCI) is increasing, and the Capabilities of Upper Extremity Test (CUE-T) is recommended for introduction in clinical trials. We calculated the minimal clinically important difference (MCID) of the CUE-T using an adjustment model with an interval of 1 month.

DESIGN:

This was a prospective study.

SETTING:

This study was conducted with participants from the Chiba Rehabilitation Center in Japan.

PARTICIPANTS:

The participants were patients with subacute CSCI.

INTERVENTIONS:

The CUE-T and spinal cord independence measure (SCIM) III were performed twice within an interval of 1 month. OUTCOME

MEASURES:

The MCID was calculated using an adjustment model based on logistic regression analysis. The participants were classified into an improvement group and a non-improvement group based on the amount of change in the two evaluations using the 10-point SCIM III MCID as an anchor.

RESULTS:

There were 52 participants (56.8 ± 13.5 years old, 45 men/7 women) with complete or incomplete CSCI 18 in the improvement group and 34 in the non-improvement group. A significant regression equation was obtained when calculating the MCID, and the total, hand, and side scores were 7.7, 2.0, and 3.7 points, respectively.

CONCLUSION:

The calculated MCID of the CUE-T in this study was 7.7 points. The results of this study provide useful criteria for implementation in clinical trials. Future studies should use patient-reported outcomes, a more recommended anchor, and calculate the MCID using methods such as the patient's condition.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article